Boehringer Ingelheim Pharma GmbH & Co. KG has synthesized NADPH oxidase 4 (NOX4) inhibitors reported to be useful for the treatment of atherosclerosis, cancer, pulmonary hypertension, inflammatory ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Zeugen, die diese Vorfälle beobachtet haben, werden gebeten, sich bei der Polizeiinspektion Ingelheim zu melden. Dieser Text basiert auf einer offiziellen Behörden-Information und wurde mit ...

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results GlobeNewswire September 05, 2024 Ingelheim, Germany and Basel ...

INGELHEIM, Germany, September 03, 2024 – Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address ...

INGELHEIM, Germany, September 03, 2024 – Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic ...

Boehringer Ingelheim, a biopharmaceutical company involved in both human and animal health, has acquired Saiba Animal Health (SAH), a company that develops therapeutic vaccines, targeting unmet needs ...

Ingelheim (ots) - In der Nacht vom Donnerstag auf Freitag kam es auf der Gau-Algesheimer Kerb zur einer Körperverletzung zum Nachteil eines 21-jährigen Mann aus Wiesbaden. Dieser habe sich mit ...

Carinne Brouillon, Mitglied der Unternehmensleitung, verantwortlich für den Geschäftsbereich Humanpharma, verlässt Boehringer Ingelheim zum 1. Oktober 2024 in den Ruhestand - Shashank Deshpande ...